RUCAPARIB and ADVERSE EVENT

Overview

ADVERSE EVENT is the #9 most commonly reported adverse reaction for RUCAPARIB, manufactured by pharmaand GmbH. There are 571 FDA adverse event reports linking RUCAPARIB to ADVERSE EVENT. This represents approximately 2.0% of all 29,211 adverse event reports for this drug.

Patients taking RUCAPARIB who experience adverse event should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ADVERSE EVENT is a less commonly reported adverse event for RUCAPARIB, but still significant enough to appear in the safety profile.

Other Side Effects of RUCAPARIB

In addition to adverse event, the following adverse reactions have been reported for RUCAPARIB:

• FATIGUE — 2,540 reports
• NAUSEA — 2,254 reports
• MALIGNANT NEOPLASM PROGRESSION — 1,182 reports
• DECREASED APPETITE — 799 reports
• DIARRHOEA — 787 reports
• CONSTIPATION — 781 reports
• VOMITING — 780 reports
• ASTHENIA — 675 reports
• CARBOHYDRATE ANTIGEN 125 INCREASED — 569 reports
• DYSGEUSIA — 565 reports

Other Drugs Associated with ADVERSE EVENT

The following drugs have also been linked to adverse event in FDA adverse event reports:

Does RUCAPARIB cause ADVERSE EVENT?

ADVERSE EVENT has been reported as an adverse event in 571 FDA reports for RUCAPARIB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ADVERSE EVENT with RUCAPARIB?

ADVERSE EVENT accounts for approximately 2.0% of all adverse event reports for RUCAPARIB, making it a notable side effect.

What should I do if I experience ADVERSE EVENT while taking RUCAPARIB?

If you experience adverse event while taking RUCAPARIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages